GlassScriptPhysician profile
Jillian Walsh
NPI 1508352048
$620.48
in general payments reported to CMS, 2019-2025
10 companies · $246 in 2025
The $246 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $209 · 2021: $79.57 · 2022: $12.13 · 2023: $31.86 · 2024: $41.40 · 2025: $246.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $320.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $319.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endologix LLC | $209.27 | 2020 | |
| Medtronic, INC. | $143.76 | 2025 | Endurant Iis |
| Cook Medical LLC | $79.97 | 2021-2023 | Cook |
| Kerecis Limited | $51.13 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| W. L. Gore & Associates, INC. | $37.63 | 2023-2025 | Gore Excluder Thoracoabdominal Branch Endoprosthesis, Gore Tag Thoracic Branch Endoprosthesis |
| Conmed Corporation | $34.09 | 2025 | Airseal |
| Janssen Pharmaceuticals, INC | $27.13 | 2021-2022 | |
| Acera Surgical, INC. | $23.81 | 2025 | Restrata Wound Matrix |
| Abbvie INC. | $13.69 | 2024 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jillian Walsh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.